DK163639C - Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper - Google Patents

Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper

Info

Publication number
DK163639C
DK163639C DK405887A DK405887A DK163639C DK 163639 C DK163639 C DK 163639C DK 405887 A DK405887 A DK 405887A DK 405887 A DK405887 A DK 405887A DK 163639 C DK163639 C DK 163639C
Authority
DK
Denmark
Prior art keywords
mixture
pharmaceutical
preparation
prostaglandin
plasminogen activator
Prior art date
Application number
DK405887A
Other languages
Danish (da)
English (en)
Other versions
DK405887D0 (da
DK405887A (da
DK163639B (da
Inventor
Brendan Joseph Richard Whittle
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10602253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK163639(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK405887D0 publication Critical patent/DK405887D0/da
Publication of DK405887A publication Critical patent/DK405887A/da
Publication of DK163639B publication Critical patent/DK163639B/da
Application granted granted Critical
Publication of DK163639C publication Critical patent/DK163639C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK405887A 1986-08-05 1987-08-04 Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper DK163639C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868619098A GB8619098D0 (en) 1986-08-05 1986-08-05 Combination
GB8619098 1986-08-05

Publications (4)

Publication Number Publication Date
DK405887D0 DK405887D0 (da) 1987-08-04
DK405887A DK405887A (da) 1988-02-06
DK163639B DK163639B (da) 1992-03-23
DK163639C true DK163639C (da) 1992-08-17

Family

ID=10602253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK405887A DK163639C (da) 1986-08-05 1987-08-04 Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper

Country Status (10)

Country Link
US (1) US4839169A (fr)
EP (1) EP0257859B1 (fr)
JP (1) JPS63115823A (fr)
AU (1) AU589283B2 (fr)
CA (1) CA1297010C (fr)
DE (1) DE3773805D1 (fr)
DK (1) DK163639C (fr)
GB (1) GB8619098D0 (fr)
NZ (1) NZ221328A (fr)
ZA (1) ZA875755B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen
EP0299376A3 (fr) * 1987-07-13 1990-01-24 William Elson Shell Compositions prostanoides et procédés pour réduire les dysfonctions des vaisseaux sanguins
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
WO1992011866A1 (fr) * 1991-01-14 1992-07-23 Duke University SEQUENCE DE LAMININE UTILES COMME ACTIVATEUR DE tPA
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158667A (en) * 1976-02-04 1979-06-19 The Upjohn Company 6-Keto PGF analogs
CA1097239A (fr) * 1976-05-11 1981-03-10 Salvador Moncada Prostacycline et preparation enzymatique
FR2469411A1 (fr) * 1979-11-15 1981-05-22 Science Union & Cie Nouveaux derives de la piperidylbenzimidazolinone, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
US4632919A (en) * 1984-09-27 1986-12-30 University Of Medicine & Dentistry Of N.J. Process for prolonging recalcification, prothrombin and thrombin times of plasma
EP0201153A3 (fr) * 1985-02-09 1987-10-07 Beecham Group Plc Enzyme modifié et son procédé de préparation
AT391812B (de) * 1985-05-28 1990-12-10 Wellcome Found Verfahren zur herstellung einer parenteralen t-pa-loesung
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen

Also Published As

Publication number Publication date
DE3773805D1 (de) 1991-11-21
AU589283B2 (en) 1989-10-05
NZ221328A (en) 1990-09-26
JPH0460586B2 (fr) 1992-09-28
AU7657287A (en) 1988-02-11
DK405887D0 (da) 1987-08-04
US4839169A (en) 1989-06-13
DK405887A (da) 1988-02-06
EP0257859A3 (en) 1989-07-26
EP0257859B1 (fr) 1991-10-16
DK163639B (da) 1992-03-23
GB8619098D0 (en) 1986-09-17
JPS63115823A (ja) 1988-05-20
CA1297010C (fr) 1992-03-10
EP0257859A2 (fr) 1988-03-02
ZA875755B (en) 1989-03-29

Similar Documents

Publication Publication Date Title
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
NO171344C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
IT1208343B (it) Siringa dentaria per iniezioni intralegamentarie
DK352686D0 (da) Steril, farmaceutisk tpa-doseringsenhed og fremgangsmaade til fremstilling deraf, beholdersaet indeholdende tpa og doseringsenhedens anvendelse
IT1233374B (it) Siringa monouso per iniezioni percutanee
DK165199C (da) Aktivatorpraeparat, fremgangsmaade til kvantitativ bestemmelse af protein c under anvendelse af praeparatet, antithrombotisk laegemiddel indeholdende praeparatet og fremgangsmaade til udvinding af aktiveret protein c under anvendelse af praeparatet
KR890700370A (ko) 의료용 피하 주사기
DK163639C (da) Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper
DK127588D0 (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK226488A (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK400887A (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
DK269986A (da) Fremgangsmaade til foroegelse af den transdermale afgivelse af laegemidler samt praeparat til transdermal administrering
DK561787A (da) Thiadiazol-derivat, fremgangsmaade til fremstilling af dette, farmaceutisk praeparat indeholdende dette samt anvendelse af dette til fremstilling af et laegemiddel
FR2578745B1 (fr) Preparations pharmaceutiques fluidifiant le sang
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
DK120789A (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK213988D0 (da) Dihydropyridinforbindelser samt medisinsk anvendelse af disse og beslaegtede forbindelser og farmaceutiske praeparater indholdende disse.
DK159434C (da) Quinoxalinforbindelser, fremgangsmaade til deres fremstilling, en anvendelse af forbindelserne og farmaceutiske praeparater hvori forbindelserne indgaar
DK159685C (da) Imidazothienopyrimidiner, farmaceutiske praeparater indeholdende disse, en anvendelse af forbindelserne og fremgangsmaade til deres fremstilling
BR6701644U (pt) Conjunto seringa medicamento descartavel
KR890008463U (ko) 일회용 주사기의 밀봉장치
DK244489D0 (da) Fremgangsmaade til terapeutisk administration af laegemidlet l-deprenyl

Legal Events

Date Code Title Description
PBP Patent lapsed